(Q37868003)

24 August 2017

1 reference

title

Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned? (English)

1 reference

24 August 2017

0 references

0 references

0 references

1

Robert D Gibbons

1 reference

24 August 2017

J John Mann

2

1 reference

24 August 2017

publication date

1 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

34

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

375-395

1 reference

https://scigraph.springernature.com/pub.10.2165/11589350-000000000-00000

24 August 2017

exact match

0 references

cites work

The role of randomized trials in testing interventions for the prevention of youth suicide

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Sixteen-year mortality in patients with affective disorder commenced on lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Epidemiological data suggest antidepressants reduce suicide risk among depressives.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Antidepressants and suicide risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Decreasing tendency of seasonality in suicide may indicate lowering rate of depressive suicides in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Suicide prevention – a medical breakthrough?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Preventing suicide and premature death by education and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Suicide and the use of antidepressants. Drug treatment of depression is inadequate

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Marked differences in antidepressant use by race in an elderly community sample: 1986-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Antidepressants and public health in Iceland. Time series analysis of national data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

The relationship between antidepressant medication use and rate of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Risk factors for adolescent suicide. A comparison of adolescent suicide victims with suicidal inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

ACNP Task Force report on SSRIs and suicidal behavior in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Suicide risk during antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Trends in hanging and firearm suicide rates in Australia: substitution of method?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Anti-depressants, suicide, and drug regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

A simulation study comparing properties of heterogeneity measures in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Post-approval drug safety surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Waiting for organ transplantation: results of an analysis by an Institute of Medicine Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Persisting decline in depression treatment after FDA warnings

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Gabapentin and suicide attempts

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Montelukast and emotional well-being as a marker for depression: results from 3 randomized, double-masked clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Rate of suicide in patients taking montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Asthma, suicidal ideation, and suicide attempts: findings from the Baltimore epidemiologic catchment area follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Smoking and suicide: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Varenicline for tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Smoking at age 18-20 and suicide during 26 years of follow-up-how can the association be explained?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Cigarettes and suicide: a prospective study of 50,000 men

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

A preliminary benefit-risk assessment of varenicline in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Varenicline: a review of its use as an aid to smoking cessation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Increased suicide attempt rate among patients interrupting use of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Self-Mutilation and Suicidal Behavior in Borderline Personality Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Maximum Likelihood Estimation of Misspecified Models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Depressed Adolescents Grown Up

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Divalproex, lithium and suicide among Medicaid patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11589350-000000000-00000

Detecting and describing heterogeneity in meta-analysis

21 January 2018

1 reference

12 December 2020

Antiepileptic drugs and risk of suicide: a nationwide study

1 reference

12 December 2020

Childhood depression and risk of suicide: a preliminary report of a longitudinal study

1 reference

12 December 2020

Youth risk behavior surveillance--United States, 2001.

1 reference

12 December 2020

Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

1 reference

12 December 2020

The relationship between antidepressant prescription rates and rate of early adolescent suicide

1 reference

12 December 2020

A comparison of heterogeneity variance estimators in combining results of studies

1 reference

12 December 2020

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs

1 reference

12 December 2020

Relationship between antidepressant treatment and suicide

1 reference

12 December 2020

Suicides are seldom prescribed antidepressants: findings from a prospective prescription database in Jämtland county, Sweden, 1985-95

1 reference

12 December 2020

Antidepressants and suicide risk in the United States, 1985-1999.

1 reference

12 December 2020

Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders.

1 reference

12 December 2020

The Maudsley long-term follow-up of child and adolescent depression

1 reference

12 December 2020

1 reference

12 December 2020

Suicide risk and treatments for patients with bipolar disorder

1 reference

12 December 2020

Lithium treatment and risk of suicidal behavior in bipolar disorder patients

1 reference

12 December 2020

Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets

1 reference

12 December 2020

Deaths: leading causes for 2000.

1 reference

12 December 2020

Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior.

1 reference

12 December 2020

Effect of lithium maintenance on suicidal behavior in major mood disorders

1 reference

12 December 2020

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

1 reference

12 December 2020

Suicide: risk factors and the public health

1 reference

12 December 2020

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants

1 reference

12 December 2020

Tricyclic drugs for depression in children and adolescents.

1 reference

12 December 2020

Antidepressants and suicide mortality

1 reference

12 December 2020

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

12 December 2020

Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998.

1 reference

12 December 2020

Suicide trends among youths and young adults aged 10-24 years--United States, 1990-2004

1 reference

12 December 2020

Emergence of intense suicidal preoccupation during fluoxetine treatment

1 reference

12 December 2020

Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation

1 reference

12 December 2020

10.2165/11589350-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1027661842

0 references

1 reference